Loading Filters
Showing 1–2 of 2 results
-
| Open
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
- C de la Piedra
- , A Alcaraz
- , J Bellmunt
- , C Meseguer
- , A Gómez-Caamano
- , M J Ribal
- , F Vázquez
- , U Anido
- , P Samper
- , E Esteban
- , J L Álvarez-Ossorio
- , P C Lara
- , L A San José
- , J A Contreras
- , A G del Alba
- , B González-Gragera
- , A J Tabernero
- , C González-Enguita
- , J M Fernández
- , A García-Escudero
- , F Gómez-Veiga
- , M J Méndez
- , J Segarra
- , J A Virizuela
- , J Carles
- , A Lassa
- , V Calderero
- , M Constela
- , D Delgado
- , A Mañas
- , A Murias
- , G Reynes
- , B Rodriguez
- , G Rubio
- , E Sánchez
- , M Unda
- , E Solsona
- , J M Martínez-Javaloyas
- , J Comet-Batlle
- , C Quicios
- , M Martín-Fernández
- , I Mahillo-Fernández
- & J Morote
British Journal of Cancer 108 , 2565–2572 -
| Open
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
- A Alcaraz
- , R González-López
- , J Morote
- , C de la Piedra
- , C Meseguer
- , E Esteban
- , M Climent
- , B González-Gragera
- , J-L Álvarez-Ossorio
- , I Chirivella
- , B Mellado
- , P-C Lara
- , F Vázquez
- , J-A Contreras
- , J Carles
- , A Murias
- , V Calderero
- , J Comet-Batlle
- , A González-del Alba
- , L León-Mateos
- , A Mañas
- , J Segarra
- , A Lassa
- , C González-Enguita
- , M-J Méndez
- , P Samper
- , M Unda
- , I Mahillo-Fernández
- & J Bellmunt
